• Profile
Close

A pilot randomized clinical trial of brief behavioral treatment for insomnia to reduce problematic cannabis use among trauma-exposed young adults

Journal of Substance Abuse Treatment Jun 18, 2021

Short NA, Zvolensky MJ, Schmidt NB, et al. - Considering that an important etiological role may be played by insomnia symptoms in substance use disorders, researchers herein examined if an improvement in sleep could result in reductions in problematic substance use among at-risk populations. They conducted a pilot RCT testing Brief Behavioral Therapy for Insomnia (BBTI) among 56 trauma-exposed cannabis using young adults. As per outcomes, BBTI is possibly efficacious in lowering insomnia symptoms as well as reducing cannabis-related problems and cravings when compared with waitlist control.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay